HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases

Cardiovascular disease (CVD) is the most fatal disease that causes sudden death, and inflammation contributes substantially to its occurrence and progression. The prevalence of CVD increases as the population ages, and the pathophysiology is complex. Anti-inflammatory and immunological modulation ar...

Full description

Bibliographic Details
Main Authors: Xialei Zheng, Junmi Lu, Jing Liu, Liufang Zhou, Yuhu He
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223009095
_version_ 1797744082260328448
author Xialei Zheng
Junmi Lu
Jing Liu
Liufang Zhou
Yuhu He
author_facet Xialei Zheng
Junmi Lu
Jing Liu
Liufang Zhou
Yuhu He
author_sort Xialei Zheng
collection DOAJ
description Cardiovascular disease (CVD) is the most fatal disease that causes sudden death, and inflammation contributes substantially to its occurrence and progression. The prevalence of CVD increases as the population ages, and the pathophysiology is complex. Anti-inflammatory and immunological modulation are the potential methods for CVD prevention and treatment. High-Mobility Group (HMG) chromosomal proteins are one of the most abundant nuclear nonhistone proteins which act as inflammatory mediators in DNA replication, transcription, and repair by producing cytokines and serving as damage-associated molecular patterns in inflammatory responses. The most common and well-studied HMG proteins are those with an HMGB domain, which participate in a variety of biological processes. HMGB1 and HMGB2 were the first members of the HMGB family to be identified and are present in all investigated eukaryotes. Our review is primarily concerned with the involvement of HMGB1 and HMGB2 in CVD. The purpose of this review is to provide a theoretical framework for diagnosing and treating CVD by discussing the structure and function of HMGB1 and HMGB2.
first_indexed 2024-03-12T15:05:36Z
format Article
id doaj.art-ae256cf7d2684ceeaf15503d070a7912
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-03-12T15:05:36Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-ae256cf7d2684ceeaf15503d070a79122023-08-13T04:52:39ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-09-01165115118HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseasesXialei Zheng0Junmi Lu1Jing Liu2Liufang Zhou3Yuhu He4Department of Cardiology, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, ChinaDepartment of Pathology, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, ChinaDepartment of Cardiology, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, ChinaDepartment of Cardiology, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; Department of Cardiovascular Medicine, the Affiliated Hospital of Youjiang Medical College for Nationalities, Baise, Guangxi 533000, ChinaDepartment of Cardiology, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; Corresponding author.Cardiovascular disease (CVD) is the most fatal disease that causes sudden death, and inflammation contributes substantially to its occurrence and progression. The prevalence of CVD increases as the population ages, and the pathophysiology is complex. Anti-inflammatory and immunological modulation are the potential methods for CVD prevention and treatment. High-Mobility Group (HMG) chromosomal proteins are one of the most abundant nuclear nonhistone proteins which act as inflammatory mediators in DNA replication, transcription, and repair by producing cytokines and serving as damage-associated molecular patterns in inflammatory responses. The most common and well-studied HMG proteins are those with an HMGB domain, which participate in a variety of biological processes. HMGB1 and HMGB2 were the first members of the HMGB family to be identified and are present in all investigated eukaryotes. Our review is primarily concerned with the involvement of HMGB1 and HMGB2 in CVD. The purpose of this review is to provide a theoretical framework for diagnosing and treating CVD by discussing the structure and function of HMGB1 and HMGB2.http://www.sciencedirect.com/science/article/pii/S0753332223009095HMGB1HMGB2Cardiovascular diseaseInflammationHigh-mobility group
spellingShingle Xialei Zheng
Junmi Lu
Jing Liu
Liufang Zhou
Yuhu He
HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases
Biomedicine & Pharmacotherapy
HMGB1
HMGB2
Cardiovascular disease
Inflammation
High-mobility group
title HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases
title_full HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases
title_fullStr HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases
title_full_unstemmed HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases
title_short HMGB family proteins: Potential biomarkers and mechanistic factors in cardiovascular diseases
title_sort hmgb family proteins potential biomarkers and mechanistic factors in cardiovascular diseases
topic HMGB1
HMGB2
Cardiovascular disease
Inflammation
High-mobility group
url http://www.sciencedirect.com/science/article/pii/S0753332223009095
work_keys_str_mv AT xialeizheng hmgbfamilyproteinspotentialbiomarkersandmechanisticfactorsincardiovasculardiseases
AT junmilu hmgbfamilyproteinspotentialbiomarkersandmechanisticfactorsincardiovasculardiseases
AT jingliu hmgbfamilyproteinspotentialbiomarkersandmechanisticfactorsincardiovasculardiseases
AT liufangzhou hmgbfamilyproteinspotentialbiomarkersandmechanisticfactorsincardiovasculardiseases
AT yuhuhe hmgbfamilyproteinspotentialbiomarkersandmechanisticfactorsincardiovasculardiseases